A detailed history of Ted Buchan & CO transactions in Zoetis Inc. stock. As of the latest transaction made, Ted Buchan & CO holds 1,230 shares of ZTS stock, worth $217,759. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,230
Previous 1,330 7.52%
Holding current value
$217,759
Previous $231 Million 4.23%
% of portfolio
0.11%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$172.58 - $196.48 $17,258 - $19,648
-100 Reduced 7.52%
1,230 $240 Million
Q2 2024

Aug 21, 2024

BUY
$145.54 - $178.83 $193,568 - $237,843
1,330 New
1,330 $231 Million
Q4 2023

Sep 06, 2024

BUY
$151.44 - $200.09 $15,144 - $20,009
100 Added 8.13%
1,330 $263 Million
Q1 2023

Sep 06, 2024

SELL
$145.48 - $175.02 $14,547 - $17,502
-100 Reduced 7.52%
1,230 $205 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Ted Buchan & CO Portfolio

Follow Ted Buchan & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ted Buchan & CO, based on Form 13F filings with the SEC.

News

Stay updated on Ted Buchan & CO with notifications on news.